|
|
| S12A5_RAT |
Slc12a5 |
Solute carrier family 12 member 5 |
1.367e-109 |
0.37
|
| NK2R_MOUSE |
Tacr2 |
Substance-K receptor |
1.768e-71 |
0.35
|
| CHLE_MOUSE |
Bche |
Cholinesterase |
2.265e-65 |
0.35
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
6.125e-64 |
0.50
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
4.831e-60 |
0.46
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
1.799e-56 |
0.50
|
| SC6A4_MOUSE |
Slc6a4 |
Sodium-dependent serotonin transporter |
2.104e-51 |
0.38
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
6.163e-49 |
0.47
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
6.525e-45 |
0.48
|
| PPIB_HUMAN |
PPIB |
Peptidyl-prolyl cis-trans isomerase B |
1.474e-44 |
0.35
|
| PPID_HUMAN |
PPID |
Peptidyl-prolyl cis-trans isomerase D |
3.537e-42 |
0.35
|
| UTS2_MACMU |
UTS2 |
Urotensin-2 |
1.332e-36 |
0.29
|
| AGTRB_RAT |
Agtr1b |
Type-1B angiotensin II receptor |
1.149e-35 |
0.33
|
| SC6A3_MOUSE |
Slc6a3 |
Sodium-dependent dopamine transporter |
3.867e-35 |
0.38
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
6.131e-35 |
0.47
|
| ACM5_HUMAN |
CHRM5 |
Muscarinic acetylcholine receptor M5 |
3.284e-34 |
0.54
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
4.53e-34 |
0.48
|
| SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
1.697e-32 |
0.40
|
| NK2R_BOVIN |
TACR2 |
Substance-K receptor |
6.21e-32 |
0.32
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
3.372e-30 |
0.66
|
| DCMC_MOUSE |
Mlycd |
Malonyl-CoA decarboxylase, mitochondrial |
6.625e-29 |
0.33
|
| CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
1.044e-27 |
0.31
|
| VMAT2_RAT |
Slc18a2 |
Synaptic vesicular amine transporter |
1.154e-27 |
0.36
|
| PPIG_HUMAN |
PPIG |
Peptidyl-prolyl cis-trans isomerase G |
1.285e-27 |
0.33
|
| THYX_PBCV1 |
|
Probable flavin-dependent thymidylate synthase |
1.293e-27 |
0.33
|
| OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
1.624e-26 |
0.48
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
9.039e-26 |
0.66
|
| GHRHR_RAT |
Ghrhr |
Growth hormone-releasing hormone receptor |
6.289e-24 |
0.30
|
| Q9TSW7_PIG |
ADRA1A |
Alpha-1A adrenergic receptor |
8.472e-24 |
0.31
|
| NK2R_RAT |
Tacr2 |
Substance-K receptor |
1.116e-23 |
0.35
|
| ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
2.614e-23 |
0.38
|
| PDIA1_HUMAN |
P4HB |
Protein disulfide-isomerase |
2.697e-23 |
0.39
|
| Q6A2E2_AEDAE |
ace-1 |
Acetylcholinesterase |
4.185e-23 |
0.28
|
| NPFF1_HUMAN |
NPFFR1 |
Neuropeptide FF receptor 1 |
4.696e-22 |
0.38
|
| EBPL_HUMAN |
EBPL |
Emopamil-binding protein-like |
7.378e-22 |
0.35
|
| NPFF2_HUMAN |
NPFFR2 |
Neuropeptide FF receptor 2 |
1.089e-21 |
0.38
|
| ADA2C_HUMAN |
ADRA2C |
Alpha-2C adrenergic receptor |
1.214e-21 |
0.38
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
2.977e-21 |
0.54
|
| 5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
4.227e-21 |
0.39
|
| US28_HCMVA |
US28 |
G-protein coupled receptor homolog US28 |
2.073e-20 |
0.29
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
2.074e-20 |
0.41
|
| 5HT2A_BOVIN |
HTR2A |
5-hydroxytryptamine receptor 2A |
5.61e-20 |
0.32
|
| DRD2_BOVIN |
DRD2 |
D(2) dopamine receptor |
6.31e-19 |
0.41
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
6.651e-19 |
0.45
|
| Q63380_RAT |
NET |
Transporter |
1.645e-18 |
0.46
|
| 5HT1A_HUMAN |
HTR1A |
5-hydroxytryptamine receptor 1A |
1.703e-18 |
0.39
|
| LKHA4_MOUSE |
Lta4h |
Leukotriene A-4 hydrolase |
2.494e-18 |
0.32
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
3.294e-18 |
0.41
|
| ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
3.916e-18 |
0.38
|
| ADA1A_RAT |
Adra1a |
Alpha-1A adrenergic receptor |
5.218e-18 |
0.38
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
2.665e-17 |
0.41
|
| ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
3.969e-17 |
0.54
|
| MCHR2_HUMAN |
MCHR2 |
Melanin-concentrating hormone receptor 2 |
4.514e-17 |
0.35
|
| CAC1C_RAT |
Cacna1c |
Voltage-dependent L-type calcium channel subunit alpha-1C |
4.931e-17 |
0.32
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
1.11e-16 |
0.45
|
| MDR1_HUMAN |
ABCB1 |
ATP-dependent translocase ABCB1 |
2.22e-16 |
0.39
|
| NK2R_HUMAN |
TACR2 |
Substance-K receptor |
2.22e-16 |
0.37
|
| NK3R_HUMAN |
TACR3 |
Neuromedin-K receptor |
3.331e-16 |
0.34
|
| Q8CGM4_CAVPO |
OPRM1 |
Mu-opioid receptor |
5.551e-16 |
0.31
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
6.661e-16 |
0.38
|
| ADA1B_MOUSE |
Adra1b |
Alpha-1B adrenergic receptor |
9.992e-16 |
0.30
|
| CCR8_HUMAN |
CCR8 |
C-C chemokine receptor type 8 |
9.992e-16 |
0.38
|
| 5HT1D_HUMAN |
HTR1D |
5-hydroxytryptamine receptor 1D |
1.332e-15 |
0.45
|
| MRP1_HUMAN |
ABCC1 |
Multidrug resistance-associated protein 1 |
1.665e-15 |
0.35
|
| PA_I000X |
PA |
Polymerase acidic protein |
2.109e-15 |
0.29
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
2.665e-15 |
0.42
|
| NK1R_CAVPO |
TACR1 |
Substance-P receptor |
2.665e-15 |
0.35
|
| OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
4.885e-15 |
0.48
|
| SC6A3_RAT |
Slc6a3 |
Sodium-dependent dopamine transporter |
4.885e-15 |
0.51
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
9.659e-15 |
0.35
|
| LKHA4_HUMAN |
LTA4H |
Leukotriene A-4 hydrolase |
9.992e-15 |
0.37
|
| SOAT1_HUMAN |
SOAT1 |
Sterol O-acyltransferase 1 |
1.01e-14 |
0.33
|
| SC6A4_RAT |
Slc6a4 |
Sodium-dependent serotonin transporter |
1.465e-14 |
0.66
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
3.642e-14 |
0.45
|
| HRH3_RAT |
Hrh3 |
Histamine H3 receptor |
3.875e-14 |
0.36
|
| ACM4_HUMAN |
CHRM4 |
Muscarinic acetylcholine receptor M4 |
6.861e-14 |
0.38
|
| CAC1D_HUMAN |
CACNA1D |
Voltage-dependent L-type calcium channel subunit alpha-1D |
3.164e-13 |
0.29
|
| VACHT_TETCF |
|
Vesicular acetylcholine transporter |
3.779e-13 |
0.36
|
| OGA_RAT |
Oga |
Protein O-GlcNAcase |
3.922e-13 |
0.29
|
| 5HT2C_RAT |
Htr2c |
5-hydroxytryptamine receptor 2C |
4.121e-13 |
0.38
|
| HRH2_HUMAN |
HRH2 |
Histamine H2 receptor |
5.018e-13 |
0.32
|
| 5HT2A_HUMAN |
HTR2A |
5-hydroxytryptamine receptor 2A |
5.046e-13 |
0.41
|
| OPRM_CAVPO |
OPRM1 |
Mu-type opioid receptor |
5.747e-13 |
0.66
|
| Q8HY88_BOVIN |
KCNK2 |
Potassium channel subfamily K member 2 |
1.288e-12 |
0.31
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
1.626e-12 |
0.33
|
| VACHT_RAT |
Slc18a3 |
Vesicular acetylcholine transporter |
1.722e-12 |
0.35
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
2.032e-12 |
0.38
|
| ACM5_RAT |
Chrm5 |
Muscarinic acetylcholine receptor M5 |
3.336e-12 |
0.30
|
| SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
3.78e-12 |
0.37
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
7.527e-12 |
0.40
|
| AGTR1_BOVIN |
AGTR1 |
Type-1 angiotensin II receptor |
1.374e-11 |
0.33
|
| ACM2_RAT |
Chrm2 |
Muscarinic acetylcholine receptor M2 |
1.381e-11 |
0.44
|
| 5HT7R_RAT |
Htr7 |
5-hydroxytryptamine receptor 7 |
1.608e-11 |
0.32
|
| Q98UH1_DANRE |
oprm1 |
Mu opioid receptor-like OR2 |
1.92e-11 |
0.31
|
| KCNJ1_HUMAN |
KCNJ1 |
ATP-sensitive inward rectifier potassium channel 1 |
2.179e-11 |
0.42
|
| ACE_HUMAN |
ACE |
Angiotensin-converting enzyme |
2.222e-11 |
0.34
|
| ADA1A_RABIT |
ADRA1A |
Alpha-1A adrenergic receptor |
2.342e-11 |
0.37
|
| OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
3.24e-11 |
0.48
|
| CALM_BOVIN |
CALM |
Calmodulin |
3.542e-11 |
0.30
|
| MDR1B_MOUSE |
Abcb1b |
ATP-dependent translocase ABCB1 |
4.205e-11 |
0.29
|
| KCNH2_HUMAN |
KCNH2 |
Potassium voltage-gated channel subfamily H member 2 |
4.265e-11 |
0.66
|
| ACM1_RAT |
Chrm1 |
Muscarinic acetylcholine receptor M1 |
6.946e-11 |
0.47
|
| FAAH1_HUMAN |
FAAH |
Fatty-acid amide hydrolase 1 |
7.961e-11 |
0.33
|
| TAAR1_HUMAN |
TAAR1 |
Trace amine-associated receptor 1 |
9.364e-11 |
0.41
|
| PCP_HUMAN |
PRCP |
Lysosomal Pro-X carboxypeptidase |
1.133e-10 |
0.42
|
| DHCR7_HUMAN |
DHCR7 |
7-dehydrocholesterol reductase |
1.517e-10 |
0.31
|
| 5HT4R_HUMAN |
HTR4 |
5-hydroxytryptamine receptor 4 |
2.067e-10 |
0.41
|
| 5HT3B_RAT |
Htr3b |
5-hydroxytryptamine receptor 3B |
2.578e-10 |
0.32
|
| NK1R_HUMAN |
TACR1 |
Substance-P receptor |
6.779e-10 |
0.37
|
| GYRB_MYCSM |
gyrB |
DNA gyrase subunit B |
7.109e-10 |
0.32
|
| RARB_HUMAN |
RARB |
Retinoic acid receptor beta |
9.473e-10 |
0.30
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
1.009e-09 |
0.35
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
1.448e-09 |
0.32
|
| AP2S1_RAT |
Ap2s1 |
AP-2 complex subunit sigma |
2.075e-09 |
0.32
|
| S1PR5_HUMAN |
S1PR5 |
Sphingosine 1-phosphate receptor 5 |
2.23e-09 |
0.33
|
| Q8WSF8_APLCA |
|
Soluble acetylcholine receptor |
2.491e-09 |
0.30
|
| NORA_STAAU |
norA |
Quinolone resistance protein NorA |
2.704e-09 |
0.32
|
| MDR1A_MOUSE |
Abcb1a |
ATP-dependent translocase ABCB1 |
2.873e-09 |
0.31
|
| P2RX1_MOUSE |
P2rx1 |
P2X purinoceptor 1 |
3.055e-09 |
0.29
|
| SSR5_HUMAN |
SSTR5 |
Somatostatin receptor type 5 |
3.327e-09 |
0.33
|
| 5HT1B_RAT |
Htr1b |
5-hydroxytryptamine receptor 1B |
4.307e-09 |
0.32
|
| KCNA3_HUMAN |
KCNA3 |
Potassium voltage-gated channel subfamily A member 3 |
5.161e-09 |
0.76
|
| SCN2A_RAT |
Scn2a |
Sodium channel protein type 2 subunit alpha |
6.156e-09 |
0.34
|
| NK3R_CAVPO |
TACR3 |
Neuromedin-K receptor |
6.798e-09 |
0.34
|
| ADA1D_RAT |
Adra1d |
Alpha-1D adrenergic receptor |
8.779e-09 |
0.34
|
| ANM6_HUMAN |
PRMT6 |
Protein arginine N-methyltransferase 6 |
1.036e-08 |
0.29
|
| ADA1A_BOVIN |
ADRA1A |
Alpha-1A adrenergic receptor |
1.039e-08 |
0.33
|
| BRS3_MOUSE |
Brs3 |
Bombesin receptor subtype-3 |
1.101e-08 |
0.30
|
| 5HT2C_HUMAN |
HTR2C |
5-hydroxytryptamine receptor 2C |
2.83e-08 |
0.39
|
| DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
4.521e-08 |
0.28
|
| FSHR_HUMAN |
FSHR |
Follicle-stimulating hormone receptor |
4.662e-08 |
0.32
|
| NOS3_HUMAN |
NOS3 |
Nitric oxide synthase, endothelial |
5.683e-08 |
0.38
|
| Q6TUJ4_PSEAI |
blaIMP-1 |
Metallo beta-lactamase |
6.101e-08 |
0.30
|
| 5HT3A_RAT |
Htr3a |
5-hydroxytryptamine receptor 3A |
6.532e-08 |
0.32
|
| HYES_RAT |
Ephx2 |
Bifunctional epoxide hydrolase 2 |
9.688e-08 |
0.35
|
| 5HT1B_HUMAN |
HTR1B |
5-hydroxytryptamine receptor 1B |
1.319e-07 |
0.38
|
| ADAM9_HUMAN |
ADAM9 |
Disintegrin and metalloproteinase domain-containing protein 9 |
1.693e-07 |
0.31
|
| EBP_HUMAN |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
2.011e-07 |
0.35
|
| PPARG_HUMAN |
PPARG |
Peroxisome proliferator-activated receptor gamma |
2.934e-07 |
0.33
|
| PA_I34A1 |
PA |
Polymerase acidic protein |
3.965e-07 |
0.29
|
| CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
4.483e-07 |
0.43
|
| PLM2_PLAFA |
|
Plasmepsin-2 |
4.943e-07 |
0.36
|
| MGLL_RAT |
Mgll |
Monoglyceride lipase |
5.529e-07 |
0.29
|
| BRS3_HUMAN |
BRS3 |
Bombesin receptor subtype-3 |
9.403e-07 |
0.30
|
| POLG_DEN2P |
|
Genome polyprotein |
1.032e-06 |
0.28
|
| 5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
1.922e-06 |
0.33
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
2.312e-06 |
0.31
|
| NR1I3_HUMAN |
NR1I3 |
Nuclear receptor subfamily 1 group I member 3 |
2.318e-06 |
0.30
|
| CASP5_HUMAN |
CASP5 |
Caspase-5 |
2.444e-06 |
0.31
|
| PRIO_SHEEP |
PRNP |
Major prion protein |
2.587e-06 |
0.29
|
| S22A1_HUMAN |
SLC22A1 |
Solute carrier family 22 member 1 |
2.971e-06 |
0.42
|
| OPRM_MOUSE |
Oprm1 |
Mu-type opioid receptor |
3.517e-06 |
0.54
|
| NOS1_RAT |
Nos1 |
Nitric oxide synthase, brain |
4.523e-06 |
0.38
|
| LPAR1_HUMAN |
LPAR1 |
Lysophosphatidic acid receptor 1 |
4.86e-06 |
0.32
|
| CCR5_MACFA |
CCR5 |
C-C chemokine receptor type 5 |
5.379e-06 |
0.28
|
| GRM6_HUMAN |
GRM6 |
Metabotropic glutamate receptor 6 |
5.722e-06 |
0.30
|
| SSR5_MOUSE |
Sstr5 |
Somatostatin receptor type 5 |
5.849e-06 |
0.28
|
| DRD1_RAT |
Drd1 |
D(1A) dopamine receptor |
6.923e-06 |
0.35
|
| P2Y12_HUMAN |
P2RY12 |
P2Y purinoceptor 12 |
7.482e-06 |
0.36
|
| CCR5_MOUSE |
Ccr5 |
C-C chemokine receptor type 5 |
8.063e-06 |
0.31
|
| ACE_RAT |
Ace |
Angiotensin-converting enzyme |
9.428e-06 |
0.32
|
| C3TDZ2_ECOLX |
fabH |
3-oxoacyl-[acyl-carrier-protein] synthase 3 |
9.444e-06 |
0.30
|